Ads
related to: biosimilars
Search results
Severe Hypoglycemia in Diabetes Drug Approved in Europe
Medscape· 15 hours agoTreatment of insulin-induced hypoglycemia with Zegalogue reduced recovery time from severe...
Should you buy Amgen’s stock above $300? | Invezz
Invezz· 3 hours ago:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. The U.S. FDA has approved Amgen’s Bkemv, the first...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 hours agoXtandi recorded alliance revenues of $418 million in the quarter, up 23% year over year. Inlyta...
JD Supra: FDA Updates Draft Guidance on Promotional Labeling and Advertising Considerations for...
JD Supra· 5 days agoOn April 25, 2024, FDA published a revised draft guidance, Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and...
BCA Research recommends overweight in Pharma as challenges dissipate By Investing.com
Investing.com· 3 days agoBCA Research advises investors to overweight their portfolios in the pharmaceutical sector,...
Novel Score Predicts Weight Loss With Semaglutide in T2D
Medscape· 2 days agoThe individualized metabolic surgery score could help set realistic weight loss targets with...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters via Yahoo News· 3 days agoAmgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex...
Advisory Panel Votes Against Once-Weekly Insulin for T1D
Medscape· 7 days agoIn a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the...
Dr. Reddy’s promotes 18-year exec to lead North America business
NJBIZ· 1 day agoMilan Kalawadia succeeds Marc Kikuchi as chief executive officer, North America. Kalawadia will also...
Why This Pharma Stock Is Upbeat Even After US FDA Action
Investing.com· 4 days agoWhile Aurobindo Pharma (NS: ARBN )'s share price was up as quarterly results impressed the street,...